Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 2/20 | 0.44 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | ACHE | P22303 | 11/20 | 0.37 |
| ▸ | BCHE | P06276 | 10/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Naphthalene SCHEMBL1332240 | 0.64 | CYP2A6 (1.00) | CYP2A6ALOX12ATMACHEALDH1A1 | |
| Naphthalene SCHEMBL1293896 | 0.64 | CYP2A6 (1.00) | CYP2A6ALOX12ATMACHEALDH1A1 | |
| Naphthalene SCHEMBL1330659 | 0.64 | CYP2A6 (1.00) | CYP2A6ALOX12ATMACHEALDH1A1 | |
| Naphthalene SCHEMBL8953 | 0.64 | CYP2A6 (1.00) | CYP2A6ALOX12ATMACHEALDH1A1 | |
| Naphthalene SCHEMBL1331142 | 0.64 | CYP2A6 (1.00) | CYP2A6ALOX12ATMACHEALDH1A1 | |
| Naphthalene SCHEMBL29358073 | 0.64 | CYP2A6 (1.00) | CYP2A6ALOX12ATMACHEALDH1A1 | |
| Naphthalene SCHEMBL30685720 | 0.64 | CYP2A6 (1.00) | CYP2A6ALOX12ATMACHEALDH1A1 | |
| Naphthalene SCHEMBL8613802 | 0.64 | CYP2A6 (1.00) | CYP2A6ALOX12ATMACHEALDH1A1 | |
| Naphthalene SCHEMBL1218988 | 0.60 | CYP2A6 (0.89) | CYP2A6ALOX12ATMACHEALDH1A1 | |
| Naphthalene SCHEMBL1901078 | 0.60 | CYP2A6 (0.89) | CYP2A6ALOX12ATMACHEALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060156485-A1 | Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof | THE PROCTER & GAMBLE COMPANY (US) | 2006-07-20 | — | — | US | claimed |
| US-7459470-B2 | N-oxide anthranylamide derivatives and their use as medicaments | SCHERING AG (DE) | 2008-12-02 | — | — | US | disclosed |
| US-20060156485-A1 | Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof | THE PROCTER & GAMBLE COMPANY (US) | 2006-07-20 | — | — | US | disclosed |
| US-6183934-B1 | FOE USE IN FORMATION OF PATTERN OF INSULATION FILM, PASSIVATION FILM, .ALPHA.-RAY SHIELDING FILM, OPTICAL WAVEGUIDE | KABUSHIKI KAISHA TOSHIBA (JP) | 2001-02-06 | — | — | US | disclosed |
| EP-0505198-B1 | A method of enhancing a luminescent reaction, luminometric assay and kits for use in the same | SANYO CHEMICAL IND LTD (JP) | 1997-01-02 | — | — | EP | disclosed |
| US-5424194-A | Chemiluminescence | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 1995-06-13 | — | — | US | disclosed |
| EP-0505198-A1 | A method of enhancing a luminescent reaction, luminometric assay and kits for use in the same | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 1992-09-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060156485-A1 | Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof | KRT18, TUBB6, DNMT1 | CYP2A6 245/4885ALOX12 1278/4885ATM 3130/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.